AEGON ASSET MANAGEMENT UK Plc reduced its position in shares of Danaher Corporation (NYSE:DHR – Free Report) by 38.6% during the 1st quarter, Holdings Channel.com reports. The firm owned 201,556 shares of the conglomerate’s stock after selling 126,591 shares during the quarter. AEGON ASSET MANAGEMENT UK Plc’s holdings in Danaher were worth $38,197,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also modified their holdings of the company. State Street Corp lifted its stake in shares of Danaher by 1.7% during the fourth quarter. State Street Corp now owns 27,681,334 shares of the conglomerate’s stock valued at $6,345,529,000 after buying an additional 472,608 shares during the period. Capital International Investors grew its stake in Danaher by 8.9% in the 4th quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock worth $4,177,386,000 after acquiring an additional 1,487,768 shares during the period. Price T Rowe Associates Inc. MD grew its stake in Danaher by 9.1% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 15,973,240 shares of the conglomerate’s stock worth $3,656,595,000 after acquiring an additional 1,334,221 shares during the period. Wellington Management Group LLP raised its holdings in Danaher by 11.2% in the 4th quarter. Wellington Management Group LLP now owns 15,076,796 shares of the conglomerate’s stock valued at $3,451,380,000 after acquiring an additional 1,517,904 shares during the last quarter. Finally, Norges Bank acquired a new position in Danaher in the 4th quarter valued at $2,177,106,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.
Danaher Stock Up 0.3%
NYSE DHR opened at $177.74 on Friday. The business has a 50 day moving average price of $179.62 and a two-hundred day moving average price of $203.07. The stock has a market cap of $125.80 billion, a PE ratio of 34.38, a P/E/G ratio of 2.26 and a beta of 0.81. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33.
Danaher Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.9%. Danaher’s dividend payout ratio (DPR) is presently 30.95%.
Wall Street Analysts Forecast Growth
DHR has been the topic of several analyst reports. Wall Street Zen cut Danaher from a “buy” rating to a “hold” rating in a report on Saturday, April 25th. HSBC dropped their target price on Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a research note on Wednesday, June 3rd. Argus reduced their target price on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research report on Friday, April 24th. Wolfe Research lowered Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday, June 1st. Finally, The Goldman Sachs Group decreased their price target on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research note on Monday, April 13th. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have issued a Hold rating to the company. According to MarketBeat.com, Danaher currently has a consensus rating of “Moderate Buy” and an average price target of $233.61.
Check Out Our Latest Report on Danaher
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Stories
- Five stocks we like better than Danaher
- 3 Retail Winners Using Cash Flow to Stay Ahead
- 3 Tech ETFs That Could Bounce Back After the AI Selloff
- 3 Penny Stocks Under $5 Backed by Real Revenue Growth
- 3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
